GB1325065A - Imidazoline derivatives - Google Patents

Imidazoline derivatives

Info

Publication number
GB1325065A
GB1325065A GB4694070A GB4694070A GB1325065A GB 1325065 A GB1325065 A GB 1325065A GB 4694070 A GB4694070 A GB 4694070A GB 4694070 A GB4694070 A GB 4694070A GB 1325065 A GB1325065 A GB 1325065A
Authority
GB
United Kingdom
Prior art keywords
general formula
formula above
isoindol
imidazo
dihydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB4694070A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
American Home Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Products Corp filed Critical American Home Products Corp
Publication of GB1325065A publication Critical patent/GB1325065A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/22Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

1325065 5 - Aryl - 2,3 - dihydro - 5H- imidazo[2,1-a]isoindol- 5 - ols AMERICAN HOME PRODUCTS CORP 2 Oct 1970 [12 Feb 1970] 46940/70 Heading C2C Novel 5 - aryl - 2,3 - dihydro - 5H - imidazo- [2,1-a]isoindol-5-ols of the general formula and their tautomeric acid addition salts of the general formula wherein R<SP>1</SP> is a phenyl, mono- or di-halophenyl, mono- or di-C 1-4 alkylphenyl, trifluoromethylphenyl, mono- or di-C 1-6 alkoxyphenyl, thienyl, pyridyl, furyl or 5,6,7,8-tetrahydro-2-naphthyl group, R<SP>2</SP> is a hydrogen or halogen atom or an amino, C 1-4 alkylamino, C 1-4 alkyl or C 1-6 alkoxy group, R<SP>3</SP> is a hydrogen atom when R<SP>2</SP> and R<SP>3</SP> are dissimilar, and when R<SP>2</SP> and R<SP>3</SP> are the same they are each a hydrogen or halogen atom or a C 1-4 alkyl or C 1-6 alkoxy group, R<SP>4</SP> and R<SP>5</SP> are each a C 1-4 alkyl group, attached to the same carbon atom, and HX is an acid, are prepared by treatment of a sulphonamide of the general formula wherein each of R<SP>6</SP> and R<SP>7</SP>SO 2 is an organosulphonyl group, with a strong acid, optional treatment of the resulting acid addition salt of the second general formula above with a base and optional salification of the resulting free base of the first general formula above. Sulphonamides of the fourth general formula above are prepared by reaction of the corresponding amine of the general formula with an organosulphonyl halide. Pharmaceutical compositions having antidepressant activity comprise, as active ingredient, a 5 - aryl - 2,3 - dihydro - 5H - imidazo- [2,1-a]isoindol-5-ol of the first general formula above or tautomeric pharmacologically acceptable acid addition salt of the second general formula above, in association with a pharmaceutically acceptable carrier, and may be administered orally or parenterally.
GB4694070A 1970-02-12 1970-10-02 Imidazoline derivatives Expired GB1325065A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1098470A 1970-02-12 1970-02-12

Publications (1)

Publication Number Publication Date
GB1325065A true GB1325065A (en) 1973-08-01

Family

ID=21748356

Family Applications (2)

Application Number Title Priority Date Filing Date
GB4694070A Expired GB1325065A (en) 1970-02-12 1970-10-02 Imidazoline derivatives
GB2099772A Expired GB1325066A (en) 1970-02-12 1970-10-02 Phthalimidine compounds

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB2099772A Expired GB1325066A (en) 1970-02-12 1970-10-02 Phthalimidine compounds

Country Status (15)

Country Link
JP (1) JPS5542997B1 (en)
BE (1) BE762824A (en)
CA (1) CA936533A (en)
CH (2) CH557350A (en)
CY (2) CY786A (en)
DE (1) DE2106694C2 (en)
EG (1) EG10508A (en)
ES (1) ES388196A1 (en)
FR (1) FR2081505B1 (en)
GB (2) GB1325065A (en)
IL (1) IL36017A (en)
MY (2) MY7500060A (en)
NL (1) NL175722C (en)
SE (1) SE410460B (en)
ZA (1) ZA71337B (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8618158B2 (en) 2008-06-25 2013-12-31 Cancer Research Technology Limited Therapeutic agents
US10526311B2 (en) 2015-09-29 2020-01-07 Astex Therapeutics Limited Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity
US10544132B2 (en) 2015-09-29 2020-01-28 Astex Therapeutics Limited Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activity
US11236047B2 (en) 2017-03-28 2022-02-01 Astex Therapeutics Limited Combination of isoindolinone derivatives with SGI-110
US11603367B2 (en) 2017-03-28 2023-03-14 Astex Therapeutics Limited Isoindolinone inhibitors of the MDM2-P53 interaction and process for making them

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2509730A1 (en) * 1981-07-17 1983-01-21 Carpibem NOVEL O-HALOGENES AND O-SUBSTITUTED HETEROCYCLE PHENOLS, PROCESS FOR THE PREPARATION THEREOF, MEDICAMENTS CONTAINING SAME, ESPECIALLY ANTI-HYPERTENISERS, AND NOVEL SYNTHETIC INTERMEDIATES
DE3403730A1 (en) * 1984-02-03 1985-08-08 Hoechst Ag, 6230 Frankfurt ISOINDOLES, METHOD FOR THEIR PRODUCTION AND THEIR USE IN AGRICULTURE
ES2052769T3 (en) * 1987-07-01 1994-07-16 Ciba Geigy Ag PROCEDURE FOR OBTAINING SUBSTITUTED IMIDAZOLONES WITH HERBICIDE ACTIVITY.
GB0419481D0 (en) * 2004-09-02 2004-10-06 Cancer Rec Tech Ltd Isoindolin-1-one derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3888846A (en) * 1967-03-30 1975-06-10 Hoffmann La Roche Process for 2(2-(1,3-diazacycloalk-2-enyl))benzophenone derivatives and 1,3-diazacycloalkenyl(2,1-a)isoindole derivatives

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8618158B2 (en) 2008-06-25 2013-12-31 Cancer Research Technology Limited Therapeutic agents
US9358222B2 (en) 2008-06-25 2016-06-07 Cancer Research Technology Limited Therapeutic agents
US10414726B2 (en) 2008-06-25 2019-09-17 Cancer Research Technology Limited Therapeutic agents
US10526311B2 (en) 2015-09-29 2020-01-07 Astex Therapeutics Limited Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity
US10544132B2 (en) 2015-09-29 2020-01-28 Astex Therapeutics Limited Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activity
US10981898B2 (en) 2015-09-29 2021-04-20 Astex Therapeutics Limited Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activity
US11261171B1 (en) 2015-09-29 2022-03-01 Astex Therapeutics Limited Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity
US11236047B2 (en) 2017-03-28 2022-02-01 Astex Therapeutics Limited Combination of isoindolinone derivatives with SGI-110
US11603367B2 (en) 2017-03-28 2023-03-14 Astex Therapeutics Limited Isoindolinone inhibitors of the MDM2-P53 interaction and process for making them

Also Published As

Publication number Publication date
CH557350A (en) 1974-12-31
ES388196A1 (en) 1974-03-01
DE2106694A1 (en) 1971-08-19
CA936533A (en) 1973-11-06
DE2106694C2 (en) 1984-04-12
GB1325066A (en) 1973-08-01
FR2081505A1 (en) 1971-12-03
SE410460B (en) 1979-10-15
ZA71337B (en) 1972-08-30
BE762824A (en) 1971-08-11
EG10508A (en) 1976-03-31
MY7500062A (en) 1975-12-31
NL7101847A (en) 1971-08-16
JPS5542997B1 (en) 1980-11-04
NL175722C (en) 1984-12-17
IL36017A0 (en) 1971-03-24
CY786A (en) 1976-06-01
NL175722B (en) 1984-07-16
MY7500060A (en) 1975-12-31
CY787A (en) 1976-06-01
IL36017A (en) 1975-03-13
FR2081505B1 (en) 1974-08-30
CH557366A (en) 1974-12-31

Similar Documents

Publication Publication Date Title
GB1309835A (en) Trialkoxy-quinazolines
GB1325065A (en) Imidazoline derivatives
GB1294763A (en) 3-oxo-2,3-dihydro-1,4-benzoxazine derivatives
GB1377231A (en) Basically substituted benzyl-phthalazinone derivatives acid addition salts thereof and process for the production thereof
GB1229651A (en)
IE40742L (en) Dimethyl diketo isoquinoline derivatives
GB1322339A (en) Imidazoline derivatives
GB1322024A (en) Benzimidazoisoindoles the preparation thereof and compositions containing the same
GB1322451A (en) 3-amino-5-benzyl-1,2,4-oxadiazoles
GB1455624A (en) Imidazoline derivatives
GB1262292A (en) Novel thiazoline derivatives, the preparation thereof and compositions containing the same
GB1256723A (en)
GB1440440A (en) Tetrahydronaphthalene derivatives
GB1174349A (en) Novel 2-Anilinomethylimidazoline Derivatives and process for the preparation thereof
GB1251147A (en)
GB1297035A (en)
GB1245155A (en) NOVEL 5-SUBSTITUTED-gamma-CARBOLINE DERIVATIVES AND THE SALTS THEREOF
GB1186062A (en) Benzonaphthyridine Derivatives
GB1367305A (en) Benzodiazocine derivatives
ES428673A1 (en) Substituted nitrobenzophenone derivatives
GB1305725A (en)
GB1181295A (en) Improvements in or relating to Naphthalene Derivatives and the Manufacture Thereof
GB1377610A (en) 5-piperidine-4-spiro- oxazolidinones method for their preparation and applications thereof
GB1306511A (en) Imidazoline derivatives
GB1273399A (en) Novel formamido-cycloalkane derivatives

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee